Recent update on treatment and preventive modalities for COVID-19 Omicron variant (B.1.1.529) in India: A comprehensive review
In India, Omicron (B1.1.529), a variant of concern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has challenged the existing drug treatments options and available vaccines. Extensive search has been done to review updated information through original research articles, meta-analys...
Main Authors: | Deep Inder, Seema Manak, Md Faiz Akram, Pawan Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Saudi Journal for Health Sciences |
Subjects: | |
Online Access: | http://www.saudijhealthsci.org/article.asp?issn=2278-0521;year=2022;volume=11;issue=2;spage=83;epage=90;aulast=Inder |
Similar Items
-
The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
by: HyokJu Ri, et al.
Published: (2022-03-01) -
Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
by: Andrés Carrazco-Montalvo, et al.
Published: (2022-05-01) -
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01) -
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
by: R Manjunath, et al.
Published: (2022-09-01) -
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
by: Zeinab Mohseni Afshar, et al.
Published: (2023-02-01)